www.varchev.com

Five cannabis stocks under $10 you need to buy

Rating:

12345
Loading...

Many top cannabis - Canadian-based stocks are still unnoticed by Wall Street. However, this is starting to change as more and more analysts are beginning to look into this sector. Not only have they begun to watch it, but also buy buy-ins for some of the hottest companies.

The cannabis industry is now starting to look like the technology sector before the dot com in the mid - 1990s. It is quite possible that some of these companies will disappear over the next ten years. But it's also very likely that some of the top companies will bring huge revenue to their investors.

Aurora Cannabis

The company has made a number of takeovers to grow and develop all of its business lines. Thus, the company gained top spot in the industry for the first quarter of the year. Aurora Cannabis (NYSE: ACB) manufactures and distributes medicinal products from cannabis. It is vertically and horizontally diversified into a number of activities and segments to optimally harness the potential of cannabis. Their products contain dry cannabis and cannabis oil. CanniMed vegan capsules and herbal products, as well as evaporators and cannabis herbal processing equipment. Jefferies rated them with a buy-in rating as well as a $ 11.36 price target.

CannTrust

CannTrust Holdings (NYSE: CTST) manufactures and distributes cannabis pharmaceuticals and medications in Canada. Sell ​​dried cannabis and cannabis oil extract to customers who have proven their medical records. The company works in partnership with Gold Coast University Hospital.

The company also focuses on nanotechnology to create new products in the fields of medicine, cosmetics, healthcare and the pet sector.

Merrill Lynch has recently begun to monitor the company by assigning a buy-in rating of $ 11.

Hexo

This is another popular company in the cannabis sector. Hexo Corp (NYSE: HEXO) is a highly diversified company that develops a diverse portfolio of cannabis products. The company is based in Quebec, Canada, being a preferred supplier for the region of this type of product. The company also makes national deliveries, with plans to do international ones.

Hexo works in partnership with Fortune 500 companies, contributing to the value of their products, developing new technology in the field, infrastructure, and offering consulting services for already established companies but not yet in the sector.

Merrill Lynch follows Hexo with a buy-in rating and a $ 10 price target.

New Age Beverages

This industry also applies to established beverage companies. New Age Beverages (NASDAQ: NBEV) is a company involved in the development, marketing, sales and distribution of beverages that are ready for direct consumption. The company's portfolio includes Coco Libre, Xing Tea, Xing Energy, Aspen Pure, Bucha Live Kombucha, Mellow Mood and One Drop.

In 2018, the company launched the Noni + Collagen product and announced that for the first two months of sales it generated $ 4 million profit. And as of January 2019, New Age is licensed to sell beverages with cannabis extract.

Alliance Global has placed them a buy rating with a $ 8 Target Target. Wall Street analysts even put even a higher target of $ 8.85.

Green Organic Dutchman

More aggressive investors may want to take a look at this company. This is a Canadian-based company that engages in research and development of cannabis production. It produces organic cannabis products, including organic dried cannabis, cannabis cannabis and cannabis oils, as well as fresh seeds used in medicine.

In June 2018, the company held a 49.18% stake in Epican, a leading manufacturer of cannabis products in Jamaica. It carries out the whole process from cultivation to collection and production.

Jefferies with a buy-in rating for the company and a $ 4.64 price target.

Photo: Flickr


 Trader Martin Nikolov

Read more:

RECCOMEND WAS THIS POST USEFUL FOR YOU?
If you think, we can improve that section,
please comment. Your oppinion is imortant for us.
WARNING: Any news, opinions, research, data or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. Varchev Finance Ltd. expressly disclaims any liability for any lost principal or profits which may arise directly or indirectly from the use of or reliance on such information. Varchev Finance Ltd. may provide information, quotes, references and links to or from other sites and blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the sites, blogs or other sources of information.
Varchev Finance

London


25 Canada Square, Level 33, office 50, Canary Wharf London, E14 5LQ +44 20 3608 6256

Universal numbers

World Financial Markets - 0700 17 600    Varchev Exchange - 0700 115 44

Varchev Finance Ltd is registered in the FCA (FINANCIAL CONDUCT AUTHORITY) with a passport in the United Kingdom: FCA, United Kingdom - registration number: 494 045, which allows provision of financial services in the United Kingdom.

Varchev Finance Ltd strictly comply with the statutes of the European directive MiFID (Markets in Financial Instruments). targeting increased efficiency, transparency and uniformity of financial instruments.
Varchev Finance Ltd is authorized and regulated by the Financial Supervision Commission - Sofia, Bulgaria: License number RG-03-02-05 / 15.03.2006

The information on this site is not intended for distribution or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.


Disclaimer:

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.

chat with dealer
chat with dealer
Cookies policy